Answers are grounded in this paper and cite their sources.
Cohort study evaluates a baseline prediction score for two-month sputum culture positivity in tuberculosis, indicating moderate discrimination for risk-adapted monitoring.
Background: Early identification of patients who will remain sputum-culture-positive at two months could support risk-adapted tuberculosis (TB) monitoring. We developed a compact baseline score from routine admission data measured before anti-TB therapy. Methods: The cohort comprised 155 adults (62 culture-positive and 93 culture-negative at two months). Random Forest ranking and correlation clustering were used as exploratory selection steps. The complete development pipeline was evaluated by repeated fully nested cross-validation; a secondary conditional analysis held the full-cohort-selected candidate set fixed. Results: The fully nested pipeline yielded a mean test-fold AUC of 0.70 ± 0.09 (fold-level percentile interval 0.53–0.85). Conditional on full-cohort predictor preselection, mean test-fold AUC was 0.74 ± 0.08, and the patient-level mean repeated out-of-fold score AUC was 0.75 (bootstrap 95% CI 0.67–0.83). At provisional thresholds of ≥2, ≥3 and ≥4 points, conditional procedure sensitivity/specificity were 0.90/0.39, 0.80/0.60 and 0.57/0.74, respectively. The conditional repeated out-of-fold Brier score was 0.200, with calibration intercept approximately 0.00 and slope 0.74. Conclusions: TB-CAST is an exploratory score with moderate internal discrimination. The fully nested result is the primary internal estimate for the complete data-driven pipeline; the conditional results and provisional thresholds require prospective external validation before clinical use.
No takes yet. Share an insight, caveat, or question.
Miulescu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: